GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
    • Scientific Advisory Board
    • Reports
      • GHTM
      • Scientific Advisory Board
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases
      • IHC – Individual health care
    • Research in numbers
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
  • Networks & Partnerships
Home / Articles / Malaria in the Spotlight on the ScienceCast Podcast: Research and Vector Control with Henrique Silveira

Malaria in the Spotlight on the ScienceCast Podcast: Research and Vector Control with Henrique Silveira

February 5, 2026

Henrique Silveira, researcher from VBD-GHTM Research Group and professor at IHMT NOVA, was the guest of the latest episode of ScienceCast, a podcast dedicated to science communication.

During the interview, Henrique Silveira explored the main current challenges in the fight against malaria, explaining the role of Anopheles mosquitoes in the transmission of the Plasmodium parasite and the biological mechanisms that influence the spread of the disease. The discussion also addressed the most recent prevention and treatment strategies, ranging from combination therapies to vaccine development, while highlighting the growing problem of drug resistance.

Vector control, considered a cornerstone in reducing malaria transmission, was another central topic of the conversation. Innovative approaches were discussed, including genetically modified mosquitoes and new repellent technologies. The interview also emphasized the global dimension of malaria, with a higher incidence in sub-Saharan Africa and a disproportionate impact on young children, as well as the crucial contribution of research to the development of public health policies.

Henrique Silveira’s participation reinforces GHTM | IHMT NOVA’s role as a leading institution in tropical health research, advanced training, and international cooperation, as well as its commitment to making scientific knowledge accessible to society.

The full episode of ScienceCast is available here:

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to print (Opens in new window) Print

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Map

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2026 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.